Regional pharmacokinetics of 5-fluorouracil in dogs: Role of the liver, Gastrointestinal tract, and lungs

Cancer Research

Volumn 58, Issue 8, 1998, Pages 1688-1694

  Kuan, Han Yi ^a,b   Smith, David E ^a,b   Ensminger, William D ^b,c   Knol, James A ^a   DeRemer, Susan J ^b   Yang, Zhaomin ^b   Stetson, Philip L ^b,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG RESEARCH; DRUG SCREENING; FEMALE; GASTROINTESTINAL TRACT; LIVER; LUNG; MALE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; DIGESTIVE SYSTEM; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUOROURACIL; HEMODYNAMIC PROCESSES; LIVER; LUNG; MALE; PANCREAS; SPLEEN;

EID: 0032522880     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Diasio, R. B., and Harris, B. E. Clinical pharmacology of 5-fluorouracil. Clin. Pharmacokinet., 16: 215-237, 1989.
2. Grem, J. L. Fluorinated pyrimidines. In: B. A. Chabner and J. M. Collins (eds.), Cancer Chemotherapy: Principles and Practice, pp. 180-224. Philadelphia: J. B. Lippincott Co., 1990.
3. Ensminger, W. D., Rosowsky, A., Raso, V., Levin, D. C., Glode, M., Come, S., Steel, G., and Frei, E., III. A clinical pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2′-deoxyuridine and 5-fluorouracil. Cancer Res., 38: 3784-3792, 1978.
4. Collins, J. M., Dedrick, R. L., King, F. G., Speyer, J. L., and Myers, C. E. Nonlinear pharmacokinetic models for 5-fluorouracil in man: intravenous and intraperitoneal routes. Clin. Pharmacol. Ther., 28: 235-246, 1980.
5. Collins, J. M. Pharmacokinetics of 5-fluorouracil infusions in the rat: comparison with man and other species. Cancer Chemother. Pharmacol., 14: 108-111, 1985.
6. Wagner, J. G., Gyves, J. W., Stetson, P. L., Walker-Andrews, S. C., Wollner, I. S., Cochran, M. K., and Ensminger, W. D. Steady-state nonlinear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusions in cancer patients. Cancer Res., 46: 1499-1506, 1986.
7. Robinson, P. J., Bass, L., Pond, S. M., Roberts, M. S., and Wagner, J. G. Clinical applicability of current pharmacokinetic models, splanchnic elimination of 5-fluorouracil in cancer patients. J. Pharmacokinet. Biopharm., 16: 229-249, 1988.
8. Naguib, F. N. M., el Kouni, M. H., and Cha, S. Enzymes of uracil catabolism in normal and neoplastic human tissues. Cancer Res., 45: 5405-5412, 1985.
9. Schaaf, L. J., Dobbs, B. R., Edwards, I. R., and Perrier, D. G. Nonlinear pharmacokinetic characteristics of 5-fluorouracil (5-FU) in colorectal cancer patients. Eur. J. Clin. Pharmacol., 32: 411-418, 1987.
10. O'Brien, D. W., Semple, H. A., Molnar, G. D., Tam, Y., Coutts, R. T., Rajotte, R. V., and Bayens-Simmonds, J. A chronic conscious dog model for direct transhepatic studies in normal and pancreatic islet cell transplanted dogs. J. Pharmacol. Methods, 25: 157-170, 1991.
11. Kuan, H-Y., Smith, D. E., Ensminger, W. D., Knol, J. A., DeRemer, S. J., Yang, Z., and Stetson, P. L. Regional pharmacokinetics of 5-bromo-2′-deoxyuridine and 5-fluorouracil in dogs: hepatic arterial versus portal venous infusions. Cancer Res., 56: 4724-4727, 1996.
12. Wagner, J. G., Stetson, P. L., Knol, J. A., Andrews, J. C., Walker-Andrews, S., Knutsen, C. A., Johnson, N., Prieskorn, D., Terrio, P., Yang, Z., Ganes, D., and Ensminger, W. D. Steady-state arterial and hepatic venous plasma concentrations of 5-bromo-2′-deoxyuridine and 5-iodo-2′-deoxyuridine in animals: drugs which are subject to both splanchnic and extra-splanchnic elimination. Sel. Cancer Ther., 5: 193-203, 1989.
13. Stetson, P. L., Maybaum, J., Shukla, U. A., and Ensminger, W. D. Simultaneous determination of thymine and 5-bromouracil in DNA hydrolysates using gas chromatography-mass spectrometry with selected-ion monitoring. J. Chromatogr., 375: 1-9, 1986.
14. Gibaldi, M., and Perrier, D. Clearance concepts. In: Pharmacokinetics, Ed. 2, pp. 319-353. New York: Marcel Dekker, Inc., 1982.
15. Wilkinson, G. R. Clearance approaches in pharmacology. Pharmacol. Rev., 39: 1-47, 1987.
16. Au, J. L-S., Walker, J. S., and Rustum, Y. Pharmacokinetic studies of 5-fluorouracil and 5′-deoxy-5-fluorouridine in rats. J. Pharmacol. Exp. Ther., 227: 174-180, 1983.
17. Altman, P. L., and Dittmer, D. S. Hepatic blood flow: mammals. In: Biology Data Book, Ed. 2, Vol. 3, pp. 1703-1706. Bethesda, MD: Federation of American Societies for Experimental Biology, 1974.
18. Altman, P. L., and Dittmer, D. S. Effect of hypothermia on circulation: vertebrates. In: Biology Data Book, Ed. 2, Vol. 3, pp. 1740-1750. Bethesda, MD: Federation of American Societies for Experimental Biology, 1974.
19. Kao, Y-H., Yang, C-Y., Chen, R. R. L., and Huang, J-D. Pulmonary elimination of 5-fluorouracil in anesthetized rats. J. Pharm. Sci., 74: 1095-1096, 1985.
20. Andersson, M., Domellöf, L., Häggmark, S., Johansson, G., Reiz, S., and Gustavsson, B. Cardiopulmonary hemodynamics and pharmacokinetics after hepatic intraarterial infusion of 5-fluorouracil (5-FU): an experimental study in the pig. Cancer Chemother. Pharmacol., 22: 251-255, 1988.
21. Covey, J. M., and Straw, J. A. Nonlinear pharmacokinetics of thymidine, thymine, and fluorouracil and their kinetic interactions in normal dogs. Cancer Res., 43: 4587-4595, 1983.
22. Ikenaka, K., Shirasaka, T., Kitano, S., and Fujii, S. Effect of uracil on metabolism of 5-fluorouracil in vitro. Gann, 70: 353-359, 1979.
23. Ho, D. H., Townsend, L., Luna, M. A., and Bodey, G. P. Distribution and inhibition of dihydrouracil dehydrogenase activities in human tissues using 5-fluorouracil as a substrate. Anticancer Res., 6: 781-784, 1986.